AVPT vs. DOCS, SNAP, IONQ, MBLY, SAIL, AUR, DAY, PCOR, PCTY, and APPF
Should you be buying AvePoint stock or one of its competitors? The main competitors of AvePoint include Doximity (DOCS), Snap (SNAP), IonQ (IONQ), Mobileye Global (MBLY), SailPoint (SAIL), Aurora Innovation (AUR), Dayforce (DAY), Procore Technologies (PCOR), Paylocity (PCTY), and AppFolio (APPF). These companies are all part of the "computer software" industry.
AvePoint vs. Its Competitors
AvePoint (NASDAQ:AVPT) and Doximity (NASDAQ:DOCS) are both computer software companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.
44.5% of AvePoint shares are owned by institutional investors. Comparatively, 87.2% of Doximity shares are owned by institutional investors. 26.2% of AvePoint shares are owned by insiders. Comparatively, 31.3% of Doximity shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
In the previous week, AvePoint had 2 more articles in the media than Doximity. MarketBeat recorded 15 mentions for AvePoint and 13 mentions for Doximity. Doximity's average media sentiment score of 1.64 beat AvePoint's score of 1.12 indicating that Doximity is being referred to more favorably in the news media.
AvePoint currently has a consensus target price of $20.80, indicating a potential upside of 29.19%. Doximity has a consensus target price of $66.21, indicating a potential downside of 1.56%. Given AvePoint's stronger consensus rating and higher possible upside, equities research analysts clearly believe AvePoint is more favorable than Doximity.
Doximity has a net margin of 36.60% compared to AvePoint's net margin of -2.21%. Doximity's return on equity of 21.75% beat AvePoint's return on equity.
Doximity has higher revenue and earnings than AvePoint. AvePoint is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.
AvePoint has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Comparatively, Doximity has a beta of 1.37, meaning that its share price is 37% more volatile than the S&P 500.
Summary
Doximity beats AvePoint on 13 of the 17 factors compared between the two stocks.
Get AvePoint News Delivered to You Automatically
Sign up to receive the latest news and ratings for AVPT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding AVPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
AvePoint Competitors List
Related Companies and Tools
This page (NASDAQ:AVPT) was last updated on 9/3/2025 by MarketBeat.com Staff